Sentences with phrase «such as infant formula»

Countries that adopt all the Code's recommendations will prohibit the advertising of breast - milk substitutes, such as infant formula, and sales promotions for and free samples of these products would be outlawed.

According to Dr Carmen Casanovas, a breastfeeding expert with WHO's Department of Nutrition for Health and Development, full implementation of the Code at a national level is «vital» to prevent the promotion of breast - milk substitutes such as infant formula.

The IMS Act - known in full as the Indian Infant Milk Substitutes, Feeding Bottles and Infant Foods Act 1992 - prohibits the payment of health officials by those involved in the supply of breast milk substitutes such as infant formula.

Iron is also added to some foods, such as infant formula and cereals.

Concern for these mothers and their infants can fuel donations of breastmilk substitutes (BMS) such as infant formula.

This can be achieved by protecting, promoting and supporting breastfeeding, identifying and targeting assistance to non-breastfed infants, enabling appropriate complementary feeding, and strongly discouraging the uncontrolled distribution and use of items that may be used as breast - milk substitutes (BMS), such as infant formula or other milk products.

WHO recommends exclusive breastfeeding for six months continued up to two years with complementary foods but too many babies in the Region are fed breast - milk substitutes, such as infant formula and «growing - up milks».

Weaning from breastfeeding means starting to breastfeed less and replacing breastfeeding with another source of nutrition, such as infant formula or solid foods.

The nation's biggest dairy exporter on Friday unveiled plans to invest $ 74 million in a cheese cut and wrap facility at Cobram in Victoria, while $ 38 million will be spent increasing production capacity for nutritionals such as infant formula, and $ 14 million is earmarked to install and commission a flexible small cup and bottle filling line at Edith Creek in Tasmania.

Danone's purchase of WhiteWave can be viewed as a «defensive» move as it looks to be less «heavily» dependant on traditional dairy sourced products such as infant formula and yogurts but experts believe it will open up opportunities to expand into new categories, such as plant based ingredients and products.

Beyond the increase in productivity there also remain questions around the complexity of Aerem's plans for processing the milk into products such as infant formula — a food highly sensitive to health regulations.

It is used for fortifying powdered products such as infant formulas, dietetic foods and dairy products.

Not exact matches

While it increases prices slightly for some product categories such as jewelry and infant formula, «the demand for foreign goods via the cross-border e-commerce channel is still expected to remain strong due to better prices compared to offline retailers, perceived quality and better variety,» she said.

However, in light of recent high - profile food scandals — such as exploding watermelons and melamine - tainted infant formula — there is understandably a lot of public opposition and mistrust towards «freaky» GM foods and China's agri - chem / agricultural technology sectors in general.

It offers many store brand medicines aimed at ailments such as cough, allergy, sinuses, as well as infant formula, animal health products, and vitamins and minerals.

A huge impact could be made right now on the death and disease attributable to the synergism between infection and malnutrition — but not with fancy hospitals, such as those found in capital cities in many developing countries, or with elaborate manufactured foods or expensive infant formulas or over-trained doctors or advanced food technologies.

We include the wording «breastfeeding is best» whenever and wherever possible and relevant, such as on infant formula packaging and in all communications.

Instant whole milk is often used to make infant formula, in recipes for baked goods and sweet confections such as caramel and chocolate candy.

Bellamy's is a wholsale distributor and sources its product from established dairy producers such as Bega Cheese - owned Tatura Milk Industries, which has the accreditation to export infant formula to China.

Infant formula companies such as Bellamy's Australia, Bubs Australia and Wattle Health have all experienced big share price hikes on demand from China, while vitamins groups Blackmores and Swisse have enjoyed enormous growth since 2014, although there have been hiccups and volatility largely stemming from regulatory shifts by Chinese authorities.

The facility produces a range of milk powders such as standard whole milk powders, speciality powders and infant formula.

A dairy innovation unique to China is the development of goat infant formula by brands such as Oli6 and Bubs, Li says.

The new facility will produce liquid dairy products such as cream and high - specification pasteurised milk for the domestic market, including ready - to - drink (RTD) infant formula and baby milk.

That means danger for those consuming such products as «organic» infant milk formula, cereal bars or high energy foods that contain the organic brown rice syrup (OBRS) as an ingredient, according to a Dartmouth College research team led by Brian Jackson.

One such product is Gerber Products Co.'s «Good Start Gentle Stage 1» infant formula which transparently labels its whey protein concentrate as «from milk, enzymatically hydrolyzed.»

Carrageenan, harvested from specific species of red seaweed, is a highly effective thickener / stabilizer found in processed foods including infant formula, plant - based beverages, deli meats, and some dairy products, such as ice cream.

One was a shift in investor interest away from companies much loved for their turbo - charged earnings potential (such as health supplements manufacturer Blackmores and Bellamy's, Australia's largest organic infant formula producer) towards long - ignored, black sheep of the market.

The change also rocked infant formula makers such as Bellamy's Organic, which was forced into a dramatic restructure earlier this year.

«It will be in a position to realise some of the plans it has talked about, such as expanding in fresh milk, increasing exports to China and lifting its market share in infant formula.

The extended ASX trading halt reinforced the wild ride shareholders have been on with Wattle in an infant formula sector where volatility has been a constant in bigger ASX - listed stocks such as Bellamy's Australia.

That means it has even outpaced the remarkable rise of other infant formula producers, both big and small, such as Bubs Australia, which has risen more than four times to 83 cents in the same period, Bellamy's which has rallied from $ 3.81 to $ 18.30 and The A2 Milk Company, which has flown from $ 2.44 to $ 12.11.

Less commonly consumed foods included other beverages such as tea, coffee, sugar - sweetened drinks, formula milk, breast milk, milk - based desserts, commercial infant foods, and egg and egg - based dishes (Table 2).

The results for the few food group intakes that were dichotomized before the heritability analysis, such as for infant formula milk and fruit juice, should not be overinterpreted because there are several indications that they might be an artifact: small numbers of pairs with at least one consumer for formula milk (15 %) and other beverages (13 %) made their distributions extremely positively skewed, and the reduced variation in the data due to dichotomizing these variables compromises power and accuracy of the parameters, therefore limiting interpretation.

If your baby has tummy issues, such as a lot of gas, constipation or even infant colic, then switching to a differnt kind of formula (for example lactose free) can make a world of difference.

The guidelines repeatedly reference breastfeeding quotas, instructs healthcare facilities to keep formula «out of view of patients and the general public,» and uses insulting language such as, «human milk fed through the mother's own breast is the normal way for human infants to be nourished.»

There are only a few indications for the use of soy - based formula milk such as infants suffering from galactosemia or rare condition characterized by hereditary deficiency of lactase and in situations where parents prefer a vegetarian diet for their baby.

In the market for infant formula, Abbott remains the leader but is facing «intense price competition «in the government - sponsored Women Infants Children program, while major rivals such as Gerber and Carnation are

If you only switch from one brand of formula to another but continue giving the same type of formula, such as going from Similac Advance to Enfamil Infant, then since they are both cow's milk - based formula, you will likely not notice any improvement in any symptoms your baby is having.

• All products should be labelled and presented in such a way as to avoid any risk of confusion between infant formulae, pre-term / specialised formulas and formulas for older babies.

At past shareholder meetings, the Chair repeatedly defended promoting infant formula with strategies such as logos on labels claiming «protects» babies, despite knowing that babies fed on breastmilk substitutes are more likely to become sick than breastfed babies and, in conditions of poverty, more likely to die.

There shall be no point - of - sale advertising, giving of samples or any other promotional device to induce sales of infant formula or follow - on formulae directly to the consumer at the retail level, such as special displays, discount coupons, premiums, special sales, loss - leaders and tie - in sales.

They mislead parents and health workers to undermine breastfeeding, inflate prices of infant formula and push products such as follow - on milks and growing - up milks that are described as unnecessary by the World Health Organisation and the NHS.»

Article 19 of the Regulations states: «Infant formula and follow - on formula shall be labelled in such a way that it enables consumers to make a clear distinction between such products so as to avoid any risk of confusion between infant formula and follow on formula.&Infant formula and follow - on formula shall be labelled in such a way that it enables consumers to make a clear distinction between such products so as to avoid any risk of confusion between infant formula and follow on formula.&infant formula and follow on formula.»

• specifies that products are labelled and presented in such a way as to avoid any risk of confusion between infant formulae, specialised formulas and formulas for older babies.

Nestlé is the target of an international boycott, and emails from thousands of boycott supporters have prompted changes, such as a promise to stop a claim that its formula is «The new «Gold Standard» in infant nutrition».

Under its new policies, Nestlé allows itself to advertise milks for older babies in countries it describes as «high risk», such as the products on the right of this flier from Armenia, which cross promote the infant formula shown on the left.

That this House is concerned that the provisions of the Infant Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cInfant Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cinfant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cinfant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to cinfant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to comply.

Nestlé, whose infant formula and baby foods are known to contribute to increased illness and long - term diseases such as diabetes, heart disease and cancers has shown nothing but disdain for the marketing rules for those products.

Companies such as Danone and Nestle promote their infant formula brands widely.

It can live in dry foods such as tea, powdered milk, and powdered infant formula.